Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ADHD:US

5.9000 USD 0.0300 0.51%

As of 20:10:00 ET on 03/26/2015.

Snapshot for Alcobra Ltd (ADHD)

Open: 5.8300 Day's Range: 5.6500 - 5.9400 Volume: 128,205
Previous Close: 5.8700 52wk Range: 3.1200 - 22.1900 1-Yr Rtn: -69.32%

Stock Chart for ADHD

No chart data available.
  • ADHD:US 5.9000
  • 1D
  • 1M
  • 1Y
5.8700
Interactive ADHD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ADHD

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.4100
Est. EPS (USD) (12/2015) -1.2770
Est. PEG Ratio -
Market Cap (M USD) 119.20
Shares Outstanding (M) 20.20
30 Day Average Volume 311,451
Price/Book (mrq) 4.0539
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ADHD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ADHD

Alcobra Ltd. operates as a biopharmaceutical company. The Company develops a patented, non-stimulant pharmaceutical drug designed to treat Attention Deficit Hyperactivity Disorder and other cognitive disorders.

Yaron DanielyPresident/CEOTomer BerkovitzChief Financial Officer
Jonathan RubinChief Medical OfficerHanna RonSenior VP:CMC
More Company Profile & Key Executives for ADHD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil